ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,712Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 1278

$552K Total Retail Price of All Prescriptions

Rank: 95 out of 1278

960 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 960 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 960 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,689 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 740 720 1 2
SIMVASTATIN 574 553 2 3
LISINOPRIL 518 477 3 1
OMEPRAZOLE 419 377 4 6
AMLODIPINE BESYLATE 384 357 5 5
ALENDRONATE SODIUM 336 324 6 18
ATENOLOL 322 283 7 11
LOSARTAN POTASSIUM 275 258 8 19
METFORMIN HCL 242 234 9 4
METOPROLOL SUCCINATE 241 223 10 23
ZOLPIDEM TARTRATE 238 224 11 16
METOPROLOL TARTRATE 216 207 12 9
PRAVASTATIN SODIUM 215 208 13 14
FENOFIBRATE 211 189 14 47
GABAPENTIN 205 177 15 12
ATORVASTATIN CALCIUM 204 187 16 15
HYDROCHLOROTHIAZIDE 190 169 17 8
HYDROCODONE-ACETAMINOPHEN 176 155 S3 18 7
FUROSEMIDE 137 132 19 10
ADACEL 125 115 20 193
LIPITOR 124 110 21 95
WARFARIN SODIUM 121 116 22 17
GEMFIBROZIL 118 108 23 54
GLIPIZIDE 117 117 24 35
TRAMADOL HCL 117 107 24 25
FINASTERIDE 115 114 26 82
TAMSULOSIN HCL 113 112 27 32
NIFEDIAC CC 112 107 28 135
FLUTICASONE PROPIONATE 110 98 29 24
TRIAMTERENE-HCTZ 109 96 30 43
CITALOPRAM HBR 106 91 31 22
POTASSIUM CHLORIDE 98 85 32 21
LOSARTAN-HYDROCHLOROTHIAZIDE 97 82 33 75
ZOSTAVAX 97 86 33 130
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 83 35 30
CLOPIDOGREL 93 80 36 45
SERTRALINE HCL 92 87 37 28
OXYBUTYNIN CHLORIDE ER 92 86 37 172
ENALAPRIL MALEATE 86 73 39 58
PANTOPRAZOLE SODIUM 80 68 40 34
LOVASTATIN 79 72 41 13
LANTUS 79 68 41 33
ALLOPURINOL 77 76 43 36
PAROXETINE HCL 76 63 44 56
VENLAFAXINE HCL ER 73 64 45 121
OXYCODONE-ACETAMINOPHEN 70 64 S2 46 29
PLAVIX 65 59 47 64
RANITIDINE HCL 65 62 47 20
ESTRADIOL 62 51 R 49 71
TERAZOSIN HCL 62 62 49 59
FLUOXETINE HCL 60 52 51 41
CIPROFLOXACIN HCL 57 53 52 53
GLIPIZIDE XL 57 53 52 101
CHLORTHALIDONE 54 52 54 171
HYDRALAZINE HCL 54 49 54 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.